Events
Rock Health Enterprise Insights panel on AI in Pharma features Iya Khalil
Everyone is talking about AI and machine learning's potential for drug discovery, clinical trial management, and precision medicine. What’s less clear is how—and to what degree—these advancements will have ripple effects across the industry and for patients. Will...
read more
Iya Khalil presents at TEDx Waltham
On Thursday, June 14th GNS Co-Founder and Chief Commercial Officer Iya Khalil will give a talk entitled "Why I believe Math Will Save My Life The Second Time Around". The talk will explore the idea of using mathematics, AI, and machine learning to understand the...
read more
GNS Co-Founders Colin Hill and Iya Khalil Take Center Stage at BIO 2018
GNS Co-founders Colin Hill and Iya Khalil will address the convergence of AI and precision medicine in a pair of panel discussions at BIO 2018. Colin will be participating in a panel titled “Cutting Waste in the Link Between Big Pharma and Payers with Precision...
read moreGNS Hosts Inaugural Precision Medicine Industry Forum
The topic of artificial intelligence (AI) and how it is driving precision medicine in healthcare was the focus of the inaugural GNS Precision Medicine Industry Forum which took place May 18th in Cambridge. More than 50 attendees representing biopharma, health plans...
read moreArc Fusion Radical Wellness Summit features Iya Khalil as machine learning expert
Iya Khalil, Co-Founder and Chief Commercial Officer of GNS Healthcare, will be one of several industry thought leaders presenting at the Arc Fusion Radical Wellness Summit on Thursday, May 3. Her presentation will focus on how machine learning can drive radical...
read moreGNS Healthcare co-founders lead discussions at the US-India BioPharma & Healthcare Summit
Iya Khalil and Colin Hill will lead discussions this coming week at the 12th annual BioPharma & Healthcare Summit hosted by the USA-India Chamber of Commerce (USAIC). The day-long strategic summit gathers senior-level industry executives, academicians, investors...
read moreWorld Medical Innovation Forum features Colin Hill as speaker on AI and Real World Evidence
Join GNS Chief Executive Officer Colin Hill at the World Medical Innovation Forum on Monday, April 23 for a discussion of the impact of artificial intelligence on clinical trials using real world evidence. The panel, which takes place from 4:05-4:55pm will explore how...
read moreGNS presents with Swedish Cancer Institute on breast cancer collaboration at AACR 2018
April 18, 2018—Today, Swedish Cancer Institute (SCI) and GNS Healthcare will present a poster at the 2018 American Association of Cancer Research (AACR) Annual Meeting. The poster reports the causal machine learning and simulation approach that will be used by Swedish...
read moreHealth Evolution Summit AI panel features GNS CEO Colin Hill
GNS Healthcare CEO Colin Hill will be a part of the panel "AI: A solution Looking for a Home?" at the Health Evolution Summit on Friday, April 20. Moderated by John Doeer, chairman of Kleiner Perkins, the panel will discuss the reality of artificial intelligence in...
read moreHBS Kraft Precision Medicine Accelerator Panel Features GNS Healthcare
Wednesday, April 11, 2018-- Today, GNS Healthcare will be participating in the Harvard Business School Kraft Precision Medicine Accelerator Roundtable. The invitation-only event brings together leaders from science, technology and business for a day of panels and...
read more